|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 473/06 | (2013.01) |
| C07D 473/06 | (2006.01) | ||
| C07F 9/6561 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61K 9/4858 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 9/2054 | (2013.01) | ||
| A61K 31/522 | (2006.01) | ||
| C07F 9/65616 | (2013.01) | ||
| A61K 31/661 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/48 | (2006.01) |
| (11) | Patento numeris | 3762386 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19764343.0 |
| Europos patento paraiškos padavimo data | 2019-03-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-01-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-01-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2019/020810 |
| Data | 2019-03-05 |
| (87) | Numeris | WO 2019/173380 |
| Data | 2019-09-12 |
| (30) | Numeris | Data | Šalis |
| 201862638737 P | 2018-03-05 | US | |
| 201862688088 P | 2018-06-21 | US |
| (72) |
LIU, Jiwen , US
ELZEIN, Elfatih , US
|
| (73) |
Teon Therapeutics, Inc. ,
555 Twin Dolphin Drive, Suite 120, Redwood City, CA 94065,
US
|
| (54) | ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF |
| ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF |